Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Total-Long-Term-Assets" stands at 41.07 Billion Hong Kong Dollars as of 06/30/2025, the highest value since 06/30/2024.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Total Long Term Assets" stands at 41.07 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.36 percent compared to the value the year prior.
The 1 year change in percent is 6.36.
The 3 year change in percent is 3.37.
The 5 year change in percent is 20.99.
The 10 year change in percent is 657.10.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Assets | 280,205,508,085.11 |